GTX28006
NFkB p50 peptide
Eine Lieferung in diese Region ist nicht möglich.
- SKU:
- GTX28006
- Zusätzliche Namen:
- nuclear factor kappa B subunit 1 , CVID12 , EBP-1 , KBF1 , NF-kB1 , NF-kappa-B1 , NF-kappaB , NFKB-p105 , NFKB-p50 , NFkappaB , p105 , p50
- Anwendung:
- IP
- Konzentration:
- 0.2 mg/ml
- Physischer Zustand:
- Liquid
- Lagerbedingungen:
- 2-8[o]C Aliquot. Store undiluted.
- Hersteller:
- Genetex
- Buffer:
- PBS, BSA, 0.1% Sodium azide.
- Immunogen:
- nuclear factor kappa B subunit 1
- Spezies:
- Human
- Uniprot:
- P19838
- Synonyme:
- CVID12;DNA-binding factor KBF1;EBP-1;KBF1;NF-kappa-B1;NF-kappaB;NF-kappabeta;NF-kB;NF-kB1;NFkappaB;NFKB-p105;NFKB-p50;nuclear factor kappa-B DNA binding subunit;nuclear factor NF-kappa-B p105 subunit;nuclear factor NF-kappa-B p50 subunit;nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
- Weitere Details:
- This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Feb 2016]
- Versandbedingungen:
- Blue Ice